Invesaro

Stocks BROS Financial statements

Financial statements

Dutch Bros Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Dutch Bros Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Revenue2383274987399661,2811,638
Cost of revenue1422113455587149411,214
Gross profit96.1116153181251340424
Selling, general and administrative65.8105265184205234263
Operating income30.311-111-2.6146.2106161
Other non-operating income-1.82-4.1-8.33-14-29.3-21.2-25.6
Pre-tax income16.984.9136
Income tax0.090.84-1.632.66.9718.418.3
Net income to minority interests00-37.9-14.58.2331.237.4
Net income00-12.7-4.751.7235.379.8
EBITDA4026.5-8642.1115199276
EPS, basic-0.28-0.090.030.340.64
EPS, diluted-0.28-0.090.030.340.64
Shares, basic (weighted)45.951.962.1104125
Shares, diluted (weighted)45.951.962.1104126

Balance sheet

FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Cash and equivalents15.631.618.520.2134293269
Receivables10.810.6129.1210.618.4
Inventory15.623.339.24736.548.9
Other current assets5.028.810.915.617.520.7
Total current assets63.161.382.3205358357
Property, plant and equipment165302365542684825
Lease right-of-use assets0169200315449
Goodwill16.518.118.721.621.621.621.6
Intangible assets11.311.18.85.422.951.51
Other non-current assets1.571.562.133.8727.225.5
Total assets2605541,1861,7642,5013,009
Accounts payable16.120.421.33032.237.6
Accrued liabilities10219.6715.826.550.3
Deferred revenue11.222.825.330.342.955.7
Short-term debt3.790.12.614.4917.33.88
Total current liabilities59.9139213138203240
Long-term debt24.43.596.393.2220196
Lease liabilities0161191309450
Other non-current liabilities0.470.680.010.010.010
Total liabilities1843409341,0881,7372,111
Total debt28.23.6110099.1238202
Paid-in capital0107146379517581
Retained earnings0-12.7-17.3-15.619.799.5
Other comprehensive income00.810.540.630.05
Shareholders' equity7694.5129364537681
Minority interests0119123312226217
Total equity77.5214252676764898
Total liabilities and equity2605541,1861,7642,5013,009
Shares outstanding154

Cash flow statement

FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Net income28.46.06-118-19.39.9566.5117
Depreciation and amortization9.6715.525.244.769.193115
Stock-based compensation6.7635.115841.739.211.518
Deferred income tax-0.06-0.13-2.661.085.9315.417.6
Change in receivables-0.61-4.220.19-1.322.84-1.47-7.79
Change in inventory0.22-4.59-7.67-15.8-7.7210.5-12.4
Change in payables3.53-0.522.151.613.93.663.71
Cash from operations56.753.580.459.9140246296
Capital expenditures-39.5-40.6-118-188-228-222-241
Acquisitions-0.53-5.09-5.39-6.0500
Cash from investing-39.9-45.6-121-193-227-212-241
Debt issued05.252001.381.65150250
Debt repaid-2.99-3.23-228-1.98-2.61-11.1-287
Share buybacks00-28800
Cash from financing-12.78.0827.6134201125-78.4
Net change in cash4.0716.1-13.11.67113160-24
Free cash flow17.213-38.1-128-88.524.754.4
Interest paid2.423.837.3517.63539.139
Income taxes paid0.10.340.891.321.732.251

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $37.89 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin25.1%Gross profit / revenue.
Operating margin9.6%Operating income / revenue.
EBITDA margin15.9%EBITDA (operating income + depreciation and amortization) / revenue.
Net margin4.9%Net income / revenue.
FCF margin5.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin19.4%Cash from operations / revenue.
Return on equity (ROE)11.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)2.7%Net income / average total assets.
Return on invested capital (ROIC)19.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue15.5%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue14.4%Capital expenditures / revenue.
D&A / revenue6.4%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y27.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y30.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y38.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y24.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y32.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y29.6%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y51.9%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y71.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y38.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y87.2%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y59.8%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y126.5%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y88.2%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y19.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y70.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y40.7%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y120.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y33.2%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y26.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y74.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y55.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y20.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y36.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y63.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y20.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y34.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.35xCurrent assets / current liabilities.
Quick ratio1.10x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.03x(Cash + short-term investments) / current liabilities.
Debt / equity0.25xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets5.9%Total debt / total assets.
Liabilities / assets71.1%Total liabilities / total assets.
Net debt-$68.1MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-0.23xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$91.4MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.7%(Goodwill + intangible assets) / total assets.
Tangible book value$774.9MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.56xRevenue / average total assets.
Fixed asset turnover2.08xRevenue / average property, plant and equipment.
Inventory turnover34.2xCost of revenue / average inventory.
Days inventory11 days365 x average inventory / cost of revenue.
Receivables turnover99.8xRevenue / average receivables.
Days sales outstanding4 days365 x average receivables / revenue.
Days payables11 days365 x average accounts payable / cost of revenue.
Cash conversion cycle3 daysDays inventory + days sales outstanding - days payables.
FCF conversion102.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow74.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.69Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$13.97Revenue / diluted weighted shares.
FCF per share$0.71Free cash flow / diluted weighted shares.
Operating cash flow per share$2.71Cash from operations / diluted weighted shares.
Book value per share$5.92Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$5.75Tangible book value / shares outstanding.
Cash per share$1.99(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$6.62BShare price x shares outstanding.
Enterprise value$6.55BMarket cap + total debt - cash - short-term investments.
P/E71.7xMarket cap / net income. Only when net income is positive.
P/S3.52xMarket cap / revenue.
P/B8.30xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book8.54xMarket cap / tangible book value, when positive.
P/FCF69.6xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF18.1xMarket cap / cash from operations, when positive.
EV/Sales3.48xEnterprise value / revenue.
EV/EBIT36.4xEnterprise value / operating income, when both are positive.
EV/EBITDA21.8xEnterprise value / EBITDA, when both are positive.
EV/FCF68.9xEnterprise value / free cash flow, when both are positive.
FCF yield1.4%Free cash flow / market cap.
Earnings yield1.4%Net income / market cap (the inverse of P/E).
What was Dutch Bros Inc.'s revenue in fiscal 2025?

Dutch Bros Inc. reported revenue of $1.64B for fiscal 2025, 27.9% higher than the year before.

Was Dutch Bros Inc. profitable in fiscal 2025?

Yes. Net income was $79.8M, a net margin of 4.9%.

How much free cash flow did Dutch Bros Inc. generate in fiscal 2025?

Cash from operations of $295.5M minus capital expenditures of $241.1M left free cash flow of $54.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Dutch Bros Inc.